Journal Information
Statistics
Follow this link to access the full text of the article
Letter to the Editor
Myositis and myocarditis with tremelimumab and durvalumab combination therapy for hepatocellular carcinoma
Miositis y miocarditis tras terapia combinada de tremelimumab y durvalumab en el carcinoma hepatocelular
Thais Lizondo López
, Iria Carro Méndez, Esther Carcelero San Martín
Corresponding author
Pharmacy Service, Division of Medicines, Hospital Clínic Barcelona, Barcelona, Spain